Document is current
Any future updates will be listed below
-
Authors
van Dort, M.J. https://orcid.org/0000-0002-0927-4206
Driessen, J.H.M.
Geusens, P.
Romme, E.A.P.M.
Smeenk, F.W.J.M.
Wouters, E.F.M.
van den Bergh, J.P.W.
-
Funding
Funding for this research was provided by:
Stichting De Weijerhorst
- License Information
-
More Information
Article History
Received: 27 July 2018
Accepted: 15 April 2019
First Online: 3 June 2019
Compliance with ethical standards
:
: Mayke J. van Dort has nothing to disclose. Piet Geusens reports grants, speaker fees, and advisory board from Amgen, grants from Pfizer, grants from MSD, grants from UCB, grants from Abbott, grants and speaker fees from Lilly, grants from BMS, grants from Novartis, grants from Roche, and grants from Will Pharma, outside the submitted work. Johanna H.M. Driessen has nothing to disclose. Elisabeth A.P.M. Romme has nothing to disclose. Frank W.J.M. Smeenk has nothing to disclose. Emiel F.M. Wouters reports board membership at Boehringer, grants and speaker fees from AstraZeneca, grants and speaker fees from GSK, speaker fees from Novartis, and speaker fees from Chiesi, outside the submitted work. Joop P.W. van den Bergh reports grants from Eli Lilly, grants from Will Pharma, and grants from Amgen, outside the submitted work.
